Invention Grant
US08426355B2 Methods of treating muscular wasting diseases using NF-κB activation inhibitors
有权
使用NF-κB激活抑制剂治疗肌肉消耗疾病的方法
- Patent Title: Methods of treating muscular wasting diseases using NF-κB activation inhibitors
- Patent Title (中): 使用NF-κB激活抑制剂治疗肌肉消耗疾病的方法
-
Application No.: US11686623Application Date: 2007-03-15
-
Publication No.: US08426355B2Publication Date: 2013-04-23
- Inventor: Denis C. Guttridge , Albert S. Baldwin
- Applicant: Denis C. Guttridge , Albert S. Baldwin
- Applicant Address: US NC Chapel Hill
- Assignee: TheraLogics, Inc.
- Current Assignee: TheraLogics, Inc.
- Current Assignee Address: US NC Chapel Hill
- Agency: Senniger Powers LLP
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K38/08 ; A61K38/04
Abstract:
Methods for treating muscular wasting diseases such as Duchenne muscular dystrophy are disclosed. Specifically, the methods include administering to a subject in need of treatment for a muscular wasting disease, an NF-κB activation inhibitor capable of blocking the activation of NF-κB.
Public/Granted literature
- US20070225315A1 Methods of Treating Muscular Wasting Diseases Using NF-kB Activation Inhibitors Public/Granted day:2007-09-27
Information query
IPC分类:
